EBOS completes two acquisitions for growth strategy

EBOS has announced the completion of two acquisitions as part of its growth strategy.

The company has acquired SVS Veterinary Supplies, a leading supplier of pet medicines and products in New Zealand, for upfront consideration of NZ$115 million, with the potential for an additional earn-out of up to NZ$10m.

The upfront acquisition price represents approximately seven times EBITDA for the 12 months to March 2025.

EBOS also acquired the remaining 10% stake in Transmedic for approximately A$35m.

To fund these acquisitions, EBOS plans to raise approximately A$200m through an underwritten placement and undertake a non-underwritten retail offer to raise up to A$50m.

The company said any excess funds raised will provide additional balance sheet capacity for future growth opportunities.